These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1054 related items for PubMed ID: 33161896

  • 1. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, Sadeghi A.
    Lipids Health Dis; 2020 Nov 08; 19(1):235. PubMed ID: 33161896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study.
    Tohidi M, Baghbani-Oskouei A, Ahanchi NS, Azizi F, Hadaegh F.
    Acta Diabetol; 2018 Oct 08; 55(10):1067-1074. PubMed ID: 30066042
    [Abstract] [Full Text] [Related]

  • 5. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study.
    Aslan Çin NN, Yardımcı H, Koç N, Uçaktürk SA, Akçil Ok M.
    J Pediatr Endocrinol Metab; 2020 May 24; 33(6):777-784. PubMed ID: 32447329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
    Blum MR, Popat RA, Nagy A, Cataldo NA, McLaughlin TL.
    J Endocrinol Invest; 2021 Oct 24; 44(10):2123-2130. PubMed ID: 33687700
    [Abstract] [Full Text] [Related]

  • 8. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
    Song do K, Lee H, Sung YA, Oh JY.
    Yonsei Med J; 2016 Nov 24; 57(6):1404-11. PubMed ID: 27593868
    [Abstract] [Full Text] [Related]

  • 9. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status.
    Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, Ping F, Li W, Li Y.
    Lipids Health Dis; 2016 Jun 07; 15():104. PubMed ID: 27267043
    [Abstract] [Full Text] [Related]

  • 10. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals.
    Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL.
    PLoS One; 2016 Jun 07; 11(3):e0149731. PubMed ID: 26930652
    [Abstract] [Full Text] [Related]

  • 11. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP, Attanayake AP, Weerarathna TP, Jayatilaka KAPW.
    PLoS One; 2021 Jun 07; 16(3):e0248469. PubMed ID: 33788827
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
    Hong Y, Yang D, Liu W, Zhao X, Chen X, Li L.
    J Biol Regul Homeost Agents; 2011 Jun 07; 25(3):365-74. PubMed ID: 22023761
    [Abstract] [Full Text] [Related]

  • 13. First-Trimester Triglyceride-Glucose Index and Triglyceride/High-Density Lipoprotein Cholesterol are Predictors of Gestational Diabetes Mellitus Among the Four Surrogate Biomarkers of Insulin Resistance.
    Ma N, Bai L, Lu Q.
    Diabetes Metab Syndr Obes; 2024 Jun 07; 17():1575-1583. PubMed ID: 38616992
    [Abstract] [Full Text] [Related]

  • 14. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.
    Gynecol Endocrinol; 2016 Jun 07; 32(1):38-41. PubMed ID: 26291816
    [Abstract] [Full Text] [Related]

  • 15. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
    Erel CT, Senturk LM, Kaleli S, Gezer A, Baysal B, Tasan E.
    Gynecol Endocrinol; 2003 Jun 07; 17(3):223-9. PubMed ID: 12857430
    [Abstract] [Full Text] [Related]

  • 16. Insight into the Predictive Power of Surrogate Diagnostic Indices for Identifying Individuals with Metabolic Syndrome.
    Hosseinkhani S, Forouzanfar K, Hadizadeh N, Razi F, Darzi S, Bandarian F.
    Endocr Metab Immune Disord Drug Targets; 2024 Jun 07; 24(11):1291-1302. PubMed ID: 38258774
    [Abstract] [Full Text] [Related]

  • 17. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G, Yildizhan B, Pekin T.
    Gynecol Endocrinol; 2019 Mar 07; 35(3):233-236. PubMed ID: 30303693
    [Abstract] [Full Text] [Related]

  • 18. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome.
    Uysal E, Tammo O, Soylemez E, Incebıyık M, Filiz D, Alci M.
    BMC Endocr Disord; 2024 Aug 28; 24(1):160. PubMed ID: 39198818
    [Abstract] [Full Text] [Related]

  • 19. Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial.
    Hooshmandi H, Ghadiri-Anari A, Ranjbar AM, Fallahzadeh H, Hosseinzadeh M, Nadjarzadeh A.
    J Ovarian Res; 2024 Jul 30; 17(1):157. PubMed ID: 39080737
    [Abstract] [Full Text] [Related]

  • 20. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents.
    Locateli JC, Lopes WA, Simões CF, de Oliveira GH, Oltramari K, Bim RH, de Souza Mendes VH, Remor JM, Lopera CA, Nardo Junior N.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1163-1170. PubMed ID: 31472061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.